Cryoport Inc (CYRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryoport Inc (CYRX) has a cash flow conversion efficiency ratio of 0.002x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.13 Million) by net assets ($490.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Cryoport Inc stock valuation for the company's overall valuation and market capitalisation.
Cryoport Inc - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Cryoport Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cryoport Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryoport Inc ranked by their cash flow conversion efficiency. Explore Cryoport Inc (CYRX) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LIGHTHOUSE PROPERTIES
F:87O
|
N/A |
|
Beta Bionics, Inc. Common Stock
NASDAQ:BBNX
|
-0.057x |
|
Amtran Technology Co Ltd
TW:2489
|
-0.032x |
|
Guangdong Hotata Technology Group Co Ltd Class A
SHG:603848
|
0.029x |
|
Xiamen East Asia Machinery Industrial Co. Ltd.
SHE:301028
|
N/A |
|
Thanh Thanh Cong Tay Ninh JSC
VN:SBT
|
0.001x |
|
Northern Dynasty Minerals Ltd
TO:NDM
|
-0.089x |
|
Renta 4 Banco S.A
MC:R4
|
0.028x |
Annual Cash Flow Conversion Efficiency for Cryoport Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of Cryoport Inc from 2004 to 2025. View Cryoport Inc stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $502.64 Million | $-8.58 Million | -0.017x | +57.97% |
| 2024-12-31 | $401.90 Million | $-16.32 Million | -0.041x | -2523.72% |
| 2023-12-31 | $489.02 Million | $-757.00K | -0.002x | +53.52% |
| 2022-12-31 | $555.84 Million | $-1.85 Million | -0.003x | -126.30% |
| 2021-12-31 | $641.83 Million | $8.13 Million | 0.013x | +132.59% |
| 2020-12-31 | $382.70 Million | $-14.87 Million | -0.039x | -270.50% |
| 2019-12-31 | $126.28 Million | $-1.32 Million | -0.010x | +87.94% |
| 2018-12-31 | $38.55 Million | $-3.35 Million | -0.087x | +56.59% |
| 2017-12-31 | $17.89 Million | $-3.58 Million | -0.200x | +80.10% |
| 2016-12-31 | $5.68 Million | $-5.72 Million | -1.007x | +20.32% |
| 2015-12-31 | $4.99 Million | $-6.31 Million | -1.264x | -112.74% |
| 2014-12-31 | $-416.30K | $-4.13 Million | 9.915x | +421.60% |
| 2013-12-31 | $-2.30 Million | $-4.38 Million | 1.901x | -18.04% |
| 2012-12-31 | $-2.06 Million | $-4.79 Million | 2.319x | +227.57% |
| 2011-12-31 | $3.73 Million | $-6.78 Million | -1.818x | -124.76% |
| 2010-12-31 | $5.95 Million | $-4.81 Million | -0.809x | -125.93% |
| 2009-12-31 | $-914.58K | $-2.85 Million | 3.120x | +344.34% |
| 2008-12-31 | $-3.68 Million | $-2.59 Million | 0.702x | +126.17% |
| 2007-12-31 | $-2.29 Million | $-710.26K | 0.310x | -47.33% |
| 2006-12-31 | $-1.96 Million | $-1.16 Million | 0.589x | +9.63% |
| 2005-12-31 | $-2.15 Million | $-1.16 Million | 0.538x | -37.68% |
| 2004-12-31 | $-1.18 Million | $-1.02 Million | 0.863x | -- |
About Cryoport Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic … Read more